Clinical Trials Logo

Accelerated Phase CML, BCR-ABL1 Positive clinical trials

View clinical trials related to Accelerated Phase CML, BCR-ABL1 Positive.

Filter by:
  • None
  • Page 1

NCT ID: NCT04666025 Recruiting - Clinical trials for Acute Myeloid Leukemia

SARS-CoV-2 Donor-Recipient Immunity Transfer

Start date: September 23, 2020
Phase:
Study type: Observational

This study investigates whether donors with previous exposure to COVID-19 can pass their immunity by hematopoietic (blood) stem cell transplant (HCT) donation to patients that have not been exposed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes the COVID19 infection. This study may provide critical information for medical decision-making and possible immunotherapy interventions in immunocompromised transplant recipients, who are at high risk for COVID19 severe illness.